ArticleCancer research2008

Targeting endoplasmic reticulum stress and Akt with OSU-03012 and gefitinib or erlotinib to overcome resistance to epidermal growth factor receptor inhibitors.

Yu-Chieh Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.